FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Giuseppe Tambussi

Research Profile

Disorders

Living Beings

HIV-1

Chemicals & Drugs

Procedures

Co-author Network

Publications

TOP 3
Francesca Cossarini; Laura Galli; Nicola Gianotti; Hamid Hasson; Adriano Lazzarin; Silvia Nozza; Stefania Salpietro; Vincenzo Spagnuolo; Giuseppe Tambussi; Simona Bossolasco; Antonella Castagna
Monotherapy with atazanavir as a simplification strategy: results from an observational study.
Silvia Nozza; Manuela Pogliaghi; Cristina Razzari; Vincenzo Spagnuolo; Giuseppe Tambussi; Stefania Chiappetta; Gessica Fontana; Elena M Faioni
Levels of soluble endothelial protein C receptor are associated with CD4+ changes in Maraviroc-treated HIV-infected patients.
Giulia Della Chiara; Claudio Fortis; Giuseppe Tambussi; Guido Poli
The rise and fall of intermittent interleukin-2 therapy in HIV infection.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Giuseppe Tambussi (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Francesca Cossarini; Laura Galli; Nicola Gianotti; Hamid Hasson; Adriano Lazzarin; Silvia Nozza; Stefania Salpietro; Vincenzo Spagnuolo; Giuseppe Tambussi; Simona Bossolasco; Antonella Castagna
Monotherapy with atazanavir as a simplification strategy: results from an observational study.
Journal of acquired immune deficiency syndromes (1999) 2012;60(3):e101-3.
2012: Silvia Nozza; Manuela Pogliaghi; Cristina Razzari; Vincenzo Spagnuolo; Giuseppe Tambussi; Stefania Chiappetta; Gessica Fontana; Elena M Faioni
Levels of soluble endothelial protein C receptor are associated with CD4+ changes in Maraviroc-treated HIV-infected patients.
PloS one 2012;7(6):e37032.
2010: Giulia Della Chiara; Claudio Fortis; Giuseppe Tambussi; Guido Poli
The rise and fall of intermittent interleukin-2 therapy in HIV infection.
European cytokine network 2010;21(3):197-201.
2010: Claudia J Dembek; Sarah Kutscher; Silvia Heltai; Simone Allgayer; Priscilla Biswas; Silvia Ghezzi; Elisa Vicenzi; Dieter Hoffmann; Peter Reitmeir; Giuseppe Tambussi; Johannes R Bogner; Paolo Lusso; Hans-J Stellbrink; Elena Santagostino; Thomas Vollbrecht; Frank D Goebel; Ulrike Protzer; R Draenert; Marco Tinelli; Guido Poli; Volker Erfle; Mauro Malnati; Antonio Cosma
Nef-specific CD45RA+ CD8+ T cells secreting MIP-1beta but not IFN-gamma are associated with nonprogressive HIV-1 infection.
AIDS research and therapy 2010;7():20.
2010: Chiara Riva; Alessia Lai; Ilaria Caramma; Stefano Corvasce; Michela Violin; Lorenzo Dehò; Francesca Prati; Cristina Rossi; MC Colombo; Amedeo Capetti; Marco Franzetti; Valeria Rossini; Giuseppe Tambussi; Massimo Ciccozzi; barbara suligoi; Cristina Mussini; Giovanni Rezza; Claudia Balotta
Transmitted HIV Type 1 drug resistance and Non-B subtypes prevalence among seroconverters and newly diagnosed patients from 1992 to 2005 in Italy.
AIDS research and human retroviruses 2010;26(1):41-9.
2008: Vincent Soriano; Anna María Geretti; Carlo Federico Perno; Gerd Fätkenheuer; Deenan Pillay; Jacques Reynes; Giuseppe Tambussi; Vincent Calvez; José Alcamí; Juergen Rockstroh
Optimal use of maraviroc in clinical practice.
AIDS (London, England) 2008;22(17):2231-40.
2008: Kehmia Titanji; Stefano Sammicheli; Angelo De Milito; Paola Mantegani; Claudio Fortis; Louise Berg; Klas Kärre; Giovanna Travi; Chiara Tassandin; Lucia Lopalco; Bence Rethi; Giuseppe Tambussi; Francesca Chiodi
Altered distribution of natural killer cell subsets identified by CD56, CD27 and CD70 in primary and chronic human immunodeficiency virus-1 infection.
Immunology 2008;123(2):164-70.
2008: Sarah Kutscher; Claudia J Dembek; Simone Allgayer; Silvia Heltai; Birgit Stadlbauer; Priscilla Biswas; Silvia Nozza; Giuseppe Tambussi; Johannes R Bogner; Hans J Stellbrink; Frank D Goebel; Paolo Lusso; Marco Tinelli; Guido Poli; Volker Erfle; Heike Pohla; Mauro Malnati; Antonio Cosma
The intracellular detection of MIP-1beta enhances the capacity to detect IFN-gamma mediated HIV-1-specific CD8 T-cell responses in a flow cytometric setting providing a sensitive alternative to the ELISPOT.
AIDS research and therapy 2008;5():22.
2007: Priscilla Biswas; Andrea Galli; Laura Galli; Chiara Tassan Din; Annunciata Vecchi; Mauro S Malnati; Adriano Lazzarin; Giuseppe Tambussi
Does cyclosporin A affect CCR5 and CXCR4 expression in primary HIV-1-infected patients?
Cytometry. Part B, Clinical cytometry 2007;72(6):433-41.
2007: Michael J Silverberg; Jacqueline Neuhaus; mark bower; Daniela Gey; Angelos Hatzakis; Keith Henry; Jose Hidalgo; Leonardo Lourtau; James D Neaton; Giuseppe Tambussi; Donald I Abrams
Risk of cancers during interrupted antiretroviral therapy in the SMART study.
AIDS (London, England) 2007;21(14):1957-63.
2007: Chiara Tassan Din; Annunciata Vecchi; Giuseppe Tambussi; Anita De Rossi; Arabella Bestetti; Priscilla Biswas
Virological responses in a patient with recent HIV-1 infection experiencing an EBV reactivation.
The new microbiologica 2007;30(3):283-5.
2007: Caroline Fluur; Bence Rethi; Pham Hong Thang; Nancy Vivar; Frida Mowafi; Lucia Lopalco; Caterina Uberti Foppa; Anders Karlsson; Giuseppe Tambussi; Francesca Chiodi
Relationship between serum IL-7 concentrations and lymphopenia upon different levels of HIV immune control.
AIDS (London, England) 2007;21(8):1048-50.
2007: Priscilla Biswas; Giuseppe Tambussi; Adriano Lazzarin
Access denied? The status of co-receptor inhibition to counter HIV entry.
Expert opinion on pharmacotherapy 2007;8(7):923-33.
2007: Lidia Ruiz; Roger Paredes; Guadalupe Gómez; Joan Romeu; Pere Domingo; Núria Pérez-Alvarez; Giuseppe Tambussi; Josep M Llibre; Javier Martínez-Picado; Francesc Vidal; Carmina R Fumaz; Bonaventura Clotet
Antiretroviral therapy interruption guided by CD4 cell counts and plasma HIV-1 RNA levels in chronically HIV-1-infected patients.
AIDS (London, England) 2007;21(2):169-78.
2006: Priscilla Biswas; Silvia Nozza; Gabriella Scarlatti; Adriano Lazzarin; Giuseppe Tambussi
Oral CCR5 inhibitors: will they make it through?
Expert opinion on investigational drugs 2006;15(5):451-64.
2006: Nicoletta Burighel; Silvia Ghezzi; Silvia Nozza; Paola Del Bianco; Adriano Lazzarin; Giuseppe Tambussi; Guido Poli; Anita De Rossi
Differential dynamics of Epstein-Barr virus in individuals infected with human immunodeficiency virus-1 receiving intermittent interleukin-2 and antiretroviral therapy.
Haematologica 2006;91(2):244-7.
2005: Livio Luzi; Elena Meneghini; Silvia Oggionni; Giuseppe Tambussi; Lucia Piceni Sereni; Adriano Lazzarin
GH treatment reduces trunkal adiposity in HIV-infected patients with lipodystrophy: a randomized placebo-controlled study.
European journal of endocrinology / European Federation of Endocrine Societies 2005;153(6):781-9.
2005: Kehmia Titanji; Francesca Chiodi; Rino Bellocco; Danika Schepis; Lyda Osorio; Chiara Tassandin; Giuseppe Tambussi; Sven Grutzmeier; Lucia Lopalco; Angelo De Milito
Primary HIV-1 infection sets the stage for important B lymphocyte dysfunctions.
AIDS (London, England) 2005;19(17):1947-55.
2005: Sabine Kinloch-de-Loes; Bruno Hoen; Don E Smith; Brigitte Autran; Fiona C Lampe; Andrew N Phillips; Li-Ean Goh; Jan Andersson; Christos M Tsoukas; Anders Sonnerborg; Giuseppe Tambussi; Pierre-Marie Girard; Mark Bloch; Manuel Battegay; Nick Carter; Raphaelle El Habib; Georgia Theofan; David A Cooper; Luc Perrin
Impact of therapeutic immunization on HIV-1 viremia after discontinuation of antiretroviral therapy initiated during acute infection.
The Journal of infectious diseases 2005;192(4):607-17.
2004: Luigi Buonaguro; Maria Tagliamonte; Maria Lina Tornesello; Elisabetta Pilotti; Claudio Casoli; Adriano Lazzarin; Giuseppe Tambussi; Massimo Ciccozzi; Giovanni Rezza; Franco M Buonaguro
Screening of HIV-1 isolates by reverse heteroduplex mobility assay and identification of non-B subtypes in Italy.
Journal of acquired immune deficiency syndromes (1999) 2004;37(2):1295-306.
2004: Donato Torre; Filippo Speranza; Silvia Ghezzi; Silvia Nozza; Giuseppe Tambussi; Laura Soldini; Fernanda Dorigatti; Adriano Lazzarin; Roberto Tambini; Guido Poli
Nitric oxide production in HIV-1 infected patients receiving intermittent cycles of interleukin-2 and antiretrovirals.
HIV clinical trials 2004;5(3):146-51.
2003: Silvana Tasca; Giuseppe Tambussi; Silvia Nozza; Brunella Capiluppi; Maria Raffaella Zocchi; Laura Soldini; Fabrizio Veglia; Guido Poli; Adriano Lazzarin; Claudio Fortis
Escape of monocyte-derived dendritic cells of HIV-1 infected individuals from natural killer cell-mediated lysis.
AIDS (London, England) 2003;17(16):2291-8.
2003: Simona Porcellini; Giuliana Vallanti; Silvia Nozza; Guido Poli; Adriano Lazzarin; Giuseppe Tambussi; Antonio G Siccardi; Fabio Grassi
Improved thymopoietic potential in aviremic HIV infected individuals treated with HAART by intermittent IL-2 administration.
AIDS (London, England) 2003;17(11):1621-30.
2003: Livio Luzi; Gianluca Perseghin; Giuseppe Tambussi; Elena Meneghini; Paola Scifo; Emanuela Pagliato; Alessandro Del Maschio; Giulio Testolin; Adriano Lazzarin
Intramyocellular lipid accumulation and reduced whole body lipid oxidation in HIV lipodystrophy.
American journal of physiology. Endocrinology and metabolism 2003;284(2):E274-80.
2002: Francesco Broccolo; Simona Bossolasco; Anna M Careddu; Giuseppe Tambussi; Adriano Lazzarin; Paola Cinque
Detection of DNA of lymphotropic herpesviruses in plasma of human immunodeficiency virus-infected patients: frequency and clinical significance.
Clinical and diagnostic laboratory immunology 2002;9(6):1222-8.
2002: Mauro S Malnati; Francesco Broccolo; Silvia Nozza; Loredana Sarmati; Silvia Ghezzi; Giuseppe Locatelli; Fanny Delfanti; Brunella Capiluppi; Anna M Careddu; Massimo Andreoni; paolo monini; Guido Poli; Adriano Lazzarin; Paolo Lusso; Giuseppe Tambussi
Retrospective analysis of HHV-8 viremia and cellular viral load in HIV-seropositive patients receiving interleukin 2 in combination with antiretroviral therapy.
Blood 2002;100(5):1575-8.
2002: Alexandre Harari; G Paolo Rizzardi; Kim Ellefsen; Donatella Ciuffreda; Patrick Champagne; Pierre-Alexandre Bart; Daniel Kaufmann; Amalio Telenti; Roland Sahli; Giuseppe Tambussi; Laurent Kaiser; Adriano Lazzarin; Luc Perrin; Giuseppe Pantaleo
Analysis of HIV-1- and CMV-specific memory CD4 T-cell responses during primary and chronic infection.
Blood 2002;100(4):1381-7.
2002: Lucinda Furci; Lucia Lopalco; Patrizia Loverro; Marina Sinnone; Giuseppe Tambussi; Adriano Lazzarin; Paolo Lusso
Non-cytotoxic inhibition of HIV-1 infection by unstimulated CD8+ T lymphocytes from HIV-exposed-uninfected individuals.
AIDS (London, England) 2002;16(7):1003-8.
2002: Claudio Fortis; Laura Soldini; Silvia Ghezzi; Stefania Colombo; Giuseppe Tambussi; Elisa Vicenzi; Nicola Gianotti; Silvia Nozza; Fabrizio Veglia; Michelangelo Murone; Adriano Lazzarin; Guido Poli
Tumor necrosis factor alpha, interleukin 2, and soluble interleukin 2 receptor levels in human immunodeficiency virus type 1-infected individuals receiving intermittent cycles of interleukin 2.
AIDS research and human retroviruses 2002;18(7):491-9.
2002: G Paolo Rizzardi; Alexandre Harari; Brunella Capiluppi; Giuseppe Tambussi; Kim Ellefsen; Donatella Ciuffreda; Patrick Champagne; Pierre-Alexandre Bart; Jean-Philippe Chave; Adriano Lazzarin; Giuseppe Pantaleo
Treatment of primary HIV-1 infection with cyclosporin A coupled with highly active antiretroviral therapy.
The Journal of clinical investigation 2002;109(5):681-8.
2002: Claudia Pastori; Claudia Barassi; Flavia B Lillo; Renato Longhi; Brunella Capiluppi; Silvia Nozza; Andrea Galli; Caterina Uberti-Foppa; Adriano Lazzarin; Giuseppe Tambussi; Lucia Lopalco
The effect of HAART on humoral immune response in primary HIV-1 infected patients.
Journal of biological regulators and homeostatic agents 2002;16(1):9-17.
2002: Brunella Capiluppi; A Saracco; Nicola Gianotti; Cristina Mussini; L Butini; L Tomasoni; M De Gennaro; L Rizzolo; G Monolo; A Cargnel; C Moioli; C Arici; V Portelli; Giuliano Rizzardini; Adriano Lazzarin; Giuseppe Tambussi
Implementation of an Italian multicentric care network for early HIV infection diagnosis: 1999-2001 report.
Journal of biological regulators and homeostatic agents 2002;16(1):73-8.
2002: Flavia B Lillo; M Grasso; Sara Lodini; Brunella Capiluppi; Adriano Lazzarin; Giuseppe Tambussi
HIV-1 DNA and RNA kinetics in primary HIV infection.
Journal of biological regulators and homeostatic agents 2002;16(1):49-52.
2002: Luigi Buonaguro; Maria Tagliamonte; Maria Lina Tornesello; Donatella Ciuffreda; Brunella Capiluppi; Lucia Lopalco; Adriano Lazzarin; Giuseppe Tambussi; Franco M Buonaguro
Molecular and phylogenetic characterization of HIV variants in Italian primary HIV infections (PHI): identification of non-B subtype variants.
Journal of biological regulators and homeostatic agents 2002;16(1):44-8.
2002: Priscilla Biswas; Andrea Galli; Brunella Capiluppi; Donatella Ciuffreda; Adriano Lazzarin; Giuseppe Tambussi
Selective enrichment of CD30-expressing cells within the blast region of lymphocytes from patients with primary HIV infection (PHI).
Journal of biological regulators and homeostatic agents 2002;16(1):33-6.
2002: Claudio Fortis; Silvana Tasca; Brunella Capiluppi; Giuseppe Tambussi
Natural killer cell function in HIV-1 infected patients.
Journal of biological regulators and homeostatic agents 2002;16(1):30-2.
2002: Alessandro Poggi; Roberta Carosio; Grazia Maria Spaggiari; Claudio Fortis; Giuseppe Tambussi; Giacomo Dell'Antonio; Elena Dal Cin; Anna Rubartelli; Maria Raffaella Zocchi
NK cell activation by dendritic cells is dependent on LFA-1-mediated induction of calcium-calmodulin kinase II: inhibition by HIV-1 Tat C-terminal domain.
Journal of immunology (Baltimore, Md. : 1950) 2002;168(1):95-101.
2001: Giuseppe Tambussi; Silvia Ghezzi; Silvia Nozza; Giuliana Vallanti; L Magenta; Monica Guffanti; A Brambilla; Elisa Vicenzi; Paola Carrera; Sara Racca; Laura Soldini; Nicola Gianotti; Michelangelo Murone; Fabrizio Veglia; Guido Poli; Adriano Lazzarin
Efficacy of low-dose intermittent subcutaneous interleukin (IL)--2 in antiviral drug--experienced human immunodeficiency virus--infected persons with detectable virus load: a controlled study of 3 il-2 regimens with antiviral drug therapy.
The Journal of infectious diseases 2001;183(10):1476-84.
2001: Nicola Gianotti; Giuseppe Tambussi; Enzo Boeri; Adriano Lazzarin
Comparison of protease genotype and phenotype in HIV-1 infected patients exposed to more than one protease inhibitor.
Journal of biological regulators and homeostatic agents 2001;15(2):166-9.
2001: Chiara Bovolenta; L Camorali; Massimiliano Mauri; Silvia Ghezzi; Silvia Nozza; Giuseppe Tambussi; Adriano Lazzarin; Guido Poli
Expression and activation of a C-terminal truncated isoform of STAT5 (STAT5 Delta) following interleukin 2 administration or AZT monotherapy in HIV-infected individuals.
Clinical immunology (Orlando, Fla.) 2001;99(1):75-81.
2001: Giulia Morsica; Giovanni Sitia; MT Bernardi; Giuseppe Tambussi; Roberto Novati; Anna de Bona; Nicola Gianotti; Adriano Lazzarin
Acute self-limiting hepatitis C after possible sexual exposure: sequence analysis of the E-2 region of the infected patient and sexual partner.
Scandinavian journal of infectious diseases 2001;33(2):116-20.
2000: G Paolo Rizzardi; Giuseppe Tambussi; Pierre-Alexandre Bart; AG Chapuis; Adriano Lazzarin; Giuseppe Pantaleo
Virological and immunological responses to HAART in asymptomatic therapy-naive HIV-1-infected subjects according to CD4 cell count.
AIDS (London, England) 2000;14(15):2257-63.
2000: Pierre-Alexandre Bart; G Paolo Rizzardi; Giuseppe Tambussi; Jean-Philippe Chave; AG Chapuis; C Graziosi; Jean-Marc Corpataux; N Halkic; Jean-Yves Meuwly; Miguel Munoz; Pascal R A Meylan; W Spreen; H McDade; Sabine Yerly; Luc Perrin; Adriano Lazzarin; Giuseppe Pantaleo
Immunological and virological responses in HIV-1-infected adults at early stage of established infection treated with highly active antiretroviral therapy.
AIDS (London, England) 2000;14(13):1887-97.
2000: Brunella Capiluppi; Donatella Ciuffreda; M Sciandra; M Marroni; Giuseppe Tambussi; Adriano Lazzarin
Metabolic disorders in a cohort of patients treated with highly aggressive antiretroviral therapies during primary HIV-1 infection.
AIDS (London, England) 2000;14(12):1861-2.
2000: Giuseppe Tambussi; Andrea Gori; Brunella Capiluppi; Claudia Balotta; Laura Papagno; B Morandini; M Di Pietro; Donatella Ciuffreda; A Saracco; Adriano Lazzarin
Neurological symptoms during primary human immunodeficiency virus (HIV) infection correlate with high levels of HIV RNA in cerebrospinal fluid.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2000;30(6):962-5.
2000: Sylvain Fleury; G Paolo Rizzardi; AG Chapuis; Giuseppe Tambussi; C Knabenhans; Eleonora Simeoni; Jean-Yves Meuwly; Jean-Marc Corpataux; Adriano Lazzarin; Frank Miedema; Giuseppe Pantaleo
Long-term kinetics of T cell production in HIV-infected subjects treated with highly active antiretroviral therapy.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(10):5393-8.
2000: Lucia Lopalco; Claudia Barassi; Claudia Pastori; Renato Longhi; Samuele E Burastero; Giuseppe Tambussi; Francesco Mazzotta; Adriano Lazzarin; Mario Clerici; Antonio G Siccardi
CCR5-reactive antibodies in seronegative partners of HIV-seropositive individuals down-modulate surface CCR5 in vivo and neutralize the infectivity of R5 strains of HIV-1 In vitro.
Journal of immunology (Baltimore, Md. : 1950) 2000;164(6):3426-33.
2000: G Paolo Rizzardi; Rob J De Boer; S Hoover; Giuseppe Tambussi; AG Chapuis; N Halkic; Pierre-Alexandre Bart; V Miller; S Staszewski; Daan W Notermans; Luc Perrin; CH Fox; J M Lange; Adriano Lazzarin; Giuseppe Pantaleo
Predicting the duration of antiviral treatment needed to suppress plasma HIV-1 RNA.
The Journal of clinical investigation 2000;105(6):777-82.
2000: H Soudeyns; G Campi; G Paolo Rizzardi; C Lenge; JF Demarest; Giuseppe Tambussi; Adriano Lazzarin; Daniel Kaufmann; Giulia Casorati; Lawrence Corey; Giuseppe Pantaleo
Initiation of antiretroviral therapy during primary HIV-1 infection induces rapid stabilization of the T-cell receptor beta chain repertoire and reduces the level of T-cell oligoclonality.
Blood 2000;95(5):1743-51.
2000: G Paolo Rizzardi; M Vaccarezza; Brunella Capiluppi; Giuseppe Tambussi; Adriano Lazzarin; Giuseppe Pantaleo
Cyclosporin A in combination with HAART in primary HIV-1 infection.
Journal of biological regulators and homeostatic agents 2000;14(1):79-81.
2000: Mauro S Malnati; Giuseppe Tambussi; L Fischetti; M Algeri; Fabrizio Veglia; Brunella Capiluppi; A Lazzarin; Paolo Lusso
Analysis of serum and plasma beta chemokines in primary HIV infection (PHI).
Journal of biological regulators and homeostatic agents 2000;14(1):75-8.
2000: Claudia Barassi; C De Santis; Claudia Pastori; P Marraccini; Donatella Ciuffreda; Brunella Capiluppi; C Bressi; Antonio G Siccardi; Adriano Lazzarin; Giuseppe Tambussi; Lucia Lopalco
Early production of HIV-1 neutralising antibodies in patients following highly active antiretroviral treatment (HAART) during primary HIV infection.
Journal of biological regulators and homeostatic agents 2000;14(1):68-74.
2000: Donatella Ciuffreda; Brunella Capiluppi; E Mastrorilli; G Balconi; Giuseppe Tambussi; Adriano Lazzarin; Flavia B Lillo
Primary HIV infection: molecular approaches in diagnosis and monitoring.
Journal of biological regulators and homeostatic agents 2000;14(1):63-7.
2000: Brunella Capiluppi; Donatella Ciuffreda; G P Quinzan; M Sciandra; M Marroni; B Morandini; P Costigliola; L Guerra; M Di Pietro; G F Fibbia; R Visonà; M Cusini; C Bressi; Giuseppe Tambussi; Adriano Lazzarin
Four drug-HAART in primary HIV-1 infection: clinical benefits and virologic parameters.
Journal of biological regulators and homeostatic agents 2000;14(1):58-62.
2000: Giuliana Vallanti; Chiara Bovolenta; A Brambilla; Giuseppe Tambussi; Adriano Lazzarin; Elisa Vicenzi; Guido Poli
Immunologic reconstitution by interleukin-2: facts and open questions.
Journal of biological regulators and homeostatic agents 2000;14(1):41-4.
2000: Alessandra Cenci; Ada Bertoli; Giuseppe Tambussi; S Menzo; Massimo Clementi; Adriano Lazzarin; Brunella Capiluppi; Donatella Ciuffreda; Federica Forbici; Stefano Aquaro; F Marcuccilli; Raffaele Caliò; Carlo Federico Perno
Viral dynamics and mutations in the pol gene during primary HIV-1 infection.
Journal of biological regulators and homeostatic agents 2000;14(1):7-10.
1999: Chiara Bovolenta; L Camorali; AL Lorini; Giuliana Vallanti; Silvia Ghezzi; Giuseppe Tambussi; Adriano Lazzarin; Guido Poli
In vivo administration of recombinant IL-2 to individuals infected by HIV down-modulates the binding and expression of the transcription factors ying-yang-1 and leader binding protein-1/late simian virus 40 factor.
Journal of immunology (Baltimore, Md. : 1950) 1999;163(12):6892-7.
1999: Giulia Morsica; Giuseppe Tambussi; Giovanni Sitia; Roberto Novati; Adriano Lazzarin; Lucia Lopalco; S Mukenge
Replication of hepatitis C virus in B lymphocytes (CD19+)
Blood 1999;94(3):1138-9.
1999: Nicola Gianotti; Francesca Moretti; Giuseppe Tambussi; Brunella Capiluppi; M Ferrari; Adriano Lazzarin
The rationale for a study on HIV-1 reverse transcriptase mutations and outcome of antiretroviral therapy with two nucleoside analogs.
Journal of biological regulators and homeostatic agents 1999;13(3):158-62.
1999: Flavia B Lillo; Donatella Ciuffreda; Fabrizio Veglia; Brunella Capiluppi; E Mastrorilli; B Vergani; Giuseppe Tambussi; Adriano Lazzarin
Viral load and burden modification following early antiretroviral therapy of primary HIV-1 infection.
AIDS (London, England) 1999;13(7):791-6.
1999: Nicola Gianotti; Francesca Moretti; Giuseppe Tambussi; Sara Racca; Silvia Presi; R Crucianelli; Paola Carrera; M Ferrari; Adriano Lazzarin
Study on mutations and antiretroviral therapy (SMART): preliminary results.
Antiviral therapy 1999;4 Suppl 3():65-9.
1998: Giuseppe Tambussi; Enzo Boeri; Paola Carrera; Nicola Gianotti; Adriano Lazzarin
Prevalence of mutation associated to resistance with nucleoside analogues in a cohort of naïve HIV-1 positive subjects during the period 1984-1997.
Journal of biological regulators and homeostatic agents 1998;12(1-2 Suppl):32-4.
1997: Lucinda Furci; Gabriella Scarlatti; Samuele E Burastero; Giuseppe Tambussi; C Colognesi; C Quillent; Renato Longhi; P Loverro; B Borgonovo; D Gaffi; E Carrow; Mauro S Malnati; Paolo Lusso; Antonio G Siccardi; Adriano Lazzarin; Alberto Beretta
Antigen-driven C-C chemokine-mediated HIV-1 suppression by CD4(+) T cells from exposed uninfected individuals expressing the wild-type CCR-5 allele.
The Journal of experimental medicine 1997;186(3):455-60.
1997: Giuseppe Pantaleo; JF Demarest; T Schacker; M Vaccarezza; OJ Cohen; Marybeth Daucher; C Graziosi; S S Schnittman; Thomas C Quinn; G M Shaw; Luc Perrin; Giuseppe Tambussi; Adriano Lazzarin; Rafick-Pierre Sekaly; H Soudeyns; Lawrence Corey; Anthony Fauci
The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremia.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(1):254-8.
1997: Silvia Ghezzi; Elisa Vicenzi; Laura Soldini; Giuseppe Tambussi; Michelangelo Murone; Adriano Lazzarin; Guido Poli
Experiences in immune reconstitution. The rationale for interleukin-2 administration to HIV-infected individuals.
Journal of biological regulators and homeostatic agents 1997;11(1-2):74-8.
1997: Giuseppe Tambussi; Flavia B Lillo; Brunella Capiluppi; E Clerici; Andrea Gori; M D Pietro; G Gavazzeni; B Morandini; Adriano Lazzarin
Primary HIV infection: clinical aspects and monitoring.
Journal of biological regulators and homeostatic agents 1997;11(1-2):53-5.
1997: G Paolo Rizzardi; Giuseppe Tambussi; Wilma Barcellini; Brunella Capiluppi; E Clerici; L L Maestra; Flavia B Lillo; Giuseppe Pantaleo; Adriano Lazzarin
Soluble CD30, tumour necrosis factor (TNF)-alpha, and TNF receptors in primary HIV-1 infection: relationship with HIV-1, RNA, clinical outcome and early antiviral therapy.
Journal of biological regulators and homeostatic agents 1997;11(1-2):43-9.
1997: Mauro S Malnati; Giuseppe Tambussi; E Clerici; S Polo; M Algeri; V Nardese; Lucinda Furci; Adriano Lazzarin; Paolo Lusso
Increased plasma levels of the C-C chemokine RANTES in patients with primary HIV-1 infection.
Journal of biological regulators and homeostatic agents 1997;11(1-2):40-2.
1997: Lucia Lopalco; Claudia Pastori; Claudia Barassi; Lucinda Furci; Samuele E Burastero; Flavia B Lillo; Enzo Boeri; Laura Soldini; Giuseppe Tambussi; Adriano Lazzarin; Alberto Beretta; Antonio G Siccardi
Heterogeneity in exposed uninfected individuals.
Journal of biological regulators and homeostatic agents 1997;11(1-2):27-31.
1996: G Paolo Rizzardi; Wilma Barcellini; Giuseppe Tambussi; Flavia B Lillo; Mauro S Malnati; L Perrin; Adriano Lazzarin
Plasma levels of soluble CD30, tumour necrosis factor (TNF)-alpha and TNF receptors during primary HIV-1 infection: correlation with HIV-1 RNA and the clinical outcome.
AIDS (London, England) 1996;10(13):F45-50.
1996: Alberto Beretta; Lucinda Furci; Samuele E Burastero; Antonio Cosma; M E Dinelli; Lucia Lopalco; C DeSantis; Giuseppe Tambussi; E Carrow; S Sabbatani; Mario Clerici; Adriano Lazzarin; Antonio G Siccardi
HIV-1-specific immunity in persistently seronegative individuals at high risk for HIV infection.
Immunology letters 1996;51(1-2):39-43.
1996: Wilma Barcellini; G Paolo Rizzardi; G Poli; Giuseppe Tambussi; C Velati; P L Meroni; Angus G Dalgleish; Adriano Lazzarin
Cytokines and soluble receptor changes in the transition from primary to early chronic HIV type 1 infection.
AIDS research and human retroviruses 1996;12(4):325-31.
1996: Samuele E Burastero; D Gaffi; Lucia Lopalco; Giuseppe Tambussi; B Borgonovo; C De Santis; C Abecasis; P Robbioni; Anna Gasparri; Adriano Lazzarin; F Celada; Antonio G Siccardi; Alberto Beretta
Autoantibodies to CD4 in HIV type 1-exposed seronegative individuals.
AIDS research and human retroviruses 1996;12(4):273-80.
1995: Giuseppe Tambussi; L Repetto; V Torri; A Saracco; L Moresco; A Antinori; R Zerboni; Adriano Lazzarin
Epidemic HIV-related Kaposi's sarcoma: a retrospective analysis and validation of TIS staging. GICAT. Gruppo Italiano Collaborativo AIDS e Tumori.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1995;6(4):383-7.
1994: Roberto Novati; Antonella Castagna; Giulia Morsica; Luca Vago; Giuseppe Tambussi; Silvia Ghezzi; Cristina Gervasoni; C Bisson; Antonella d'Arminio Monforte; Adriano Lazzarin
Polymerase chain reaction for Toxoplasma gondii DNA in the cerebrospinal fluid of AIDS patients with focal brain lesions.
AIDS (London, England) 1994;8(12):1691-4.
1994: Giuseppe Tambussi; V Albarello; Andrea Gori; C Bisson; Adriano Lazzarin
Transitory expansion of a CD3+TcR gamma/delta+CD16+ lymphocytic population in two patients with advanced human immunodeficiency virus infection and high levels of natural killer activity.
AIDS research and human retroviruses 1994;10(6):711-5.
1991: Giuseppe Tambussi; Anna Lisa Ridolfo; Andrea Gori; V Albarello; Massimo Galli; Mauro Moroni
Natural killer cytotoxic test in the presence of phytohemagglutinin distinguishes between patients in the early and late stages of human immunodeficiency virus infection.
The Journal of infectious diseases 1991;164(5):1027-8.
1991: C Negri; A Saracco; Giuseppe Tambussi; A Ruggieri; Adriano Lazzarin
[Respiratory complications in 44 patients with acquired immunodeficiency syndrome].
Bollettino dell'Istituto sieroterapico milanese 1991;70(1-2):487-93.
1991: A Lazzarin; A Danise; Antonella d'Arminio Monforte; Giuseppe Tambussi; M Moroni
[Opportunistic infections and tumors in AIDS].
Giornale italiano di chemioterapia 1991;38(1-3):87-9.
1988: Adriano Lazzarin; C Negri; Giuseppe Tambussi; A Saracco; Massimo Galli; P Crocchiolo; L Irato; Antonella Castagna; Mauro Moroni
T-lymphocyte subsets and delayed type hypersensitivity as classification parameters for HIV infection among drug-addicts.
Journal of clinical & laboratory immunology 1988;25(4):157-60.